Ropivacaine HCL
IRB00133736
Phase 3 small_molecule active
Quick answer
Ropivacaine HCL for Renal Carcinoma is a Phase 3 program (small_molecule) at Atrium Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Atrium Therapeutics
- Indication
- Renal Carcinoma
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active